Literature DB >> 16497285

The ubiquitin-proteasome system: focus on the heart.

Oliver Zolk1, Carolus Schenke, Antonio Sarikas.   

Abstract

Proteasomes are the main non-lysosomal multicatalytic protease complexes that are involved in the degradation of most intracellular proteins. The substrate proteins are marked by ubiquitin, which serves as a tag for their regulated proteasomal destruction. One major function of the ubiquitin-proteasome system (UPS) is to prevent accumulation of non-functional, potentially toxic proteins. Moreover, it has become clear that the UPS is involved in most aspects of eukaryotic biology, such as intracellular signaling, transcriptional control, or regulation of cell death. Recent studies demonstrated that the UPS regulates receptor internalization, hypertrophic response, apoptosis, and tolerance to ischemia and reperfusion in cardiomyocytes. Since structural remodeling of the myocardium, ischemia-reperfusion injury, and myocardial cell loss are important components in the genesis of progressive heart failure, these findings suggest a pathophysiological role of the UPS. This review briefly summarizes present knowledge about structure and function of the proteasome in the heart and discusses the relevance of the UPS for cardiac diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497285     DOI: 10.1016/j.cardiores.2005.12.021

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  43 in total

1.  Physalin B not only inhibits the ubiquitin-proteasome pathway but also induces incomplete autophagic response in human colon cancer cells in vitro.

Authors:  Yi-ming Ma; Wei Han; Jia Li; Li-hong Hu; Yu-bo Zhou
Journal:  Acta Pharmacol Sin       Date:  2015-03-23       Impact factor: 6.150

Review 2.  Seven-transmembrane receptors and ubiquitination.

Authors:  Sudha K Shenoy
Journal:  Circ Res       Date:  2007-04-27       Impact factor: 17.367

3.  Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.

Authors:  Mohammad A M Ali; Woo Jung Cho; Bryan Hudson; Zamaneh Kassiri; Henk Granzier; Richard Schulz
Journal:  Circulation       Date:  2010-11-01       Impact factor: 29.690

Review 4.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

Authors:  Lucie Carrier; Saskia Schlossarek; Monte S Willis; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

5.  Exogenous ubiquitin reduces inflammatory response and preserves myocardial function 3 days post-ischemia-reperfusion injury.

Authors:  Stephanie L C Scofield; Suman Dalal; Kristina A Lim; Patsy R Thrasher; Christopher R Daniels; Jonathan M Peterson; Mahipal Singh; Krishna Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-25       Impact factor: 4.733

Review 6.  Minireview: ubiquitination-regulated G protein-coupled receptor signaling and trafficking.

Authors:  Verónica Alonso; Peter A Friedman
Journal:  Mol Endocrinol       Date:  2013-03-07

7.  Extracellular ubiquitin modulates cardiac fibroblast phenotype and function via its interaction with CXCR4.

Authors:  Stephanie L C Scofield; Christopher R Daniels; Suman Dalal; Jonathan A Millard; Mahipal Singh; Krishna Singh
Journal:  Life Sci       Date:  2018-09-05       Impact factor: 5.037

Review 8.  Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH).

Authors:  Federico Cacciapuoti
Journal:  Am J Cardiovasc Dis       Date:  2014-01-15

9.  Extracellular ubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3beta and mitochondrial pathways.

Authors:  Mahipal Singh; Marina Roginskaya; Suman Dalal; Bindu Menon; Ekaterina Kaverina; Marvin O Boluyt; Krishna Singh
Journal:  Cardiovasc Res       Date:  2009-12-16       Impact factor: 10.787

Review 10.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.